close read more

Pasteur-Weizmann/Servier Prize 2021: Prof. Catherine Lubetzki awarded for her work in the treatment of multiple sclerosis


Pasteur-Weizmann/Servier Prize 2021: Prof. Catherine Lubetzki awarded for her work in the treatment of multiple sclerosis

The 7th Pasteur-Weizmann/Servier Prize has just been awarded to Prof. Catherine Lubetzki, Head of the University Medical Neuroscience Department of AP-HP Sorbonne University and Medical Director of the Paris Brain Institute. This international prize, dedicated this year to neurodegenerative pathologies, rewards the career of the clinical researcher, dedicated to the myelin regeneration in the treatment of multiple sclerosis.


Multiple sclerosis (MS) is a disease that currently affects 50 to 300 people in 100,000 (1), for which preventing the progression of disability remains a therapeutic challenge.


For more than 30 years, Catherine Lubetzki and her team’s research has focused on the repair mechanisms of the central nervous system in patients with multiple sclerosis. In particular, they have made it possible to develop experimental models, understand the mechanisms involved and identify therapeutic targets leading to the introduction of clinical trials. In addition, the imaging work carried out has revealed inter-individual heterogeneity in myelin repair capacities.


The Pasteur-Weizmann/Servier Prize will be awarded to the research team “Remyelination in multiple sclerosis: from biology to clinical translation” and officially presented to the clinical researcher on December 14 during a ceremony at the Collège de France (Paris), preceded by a symposium on neurodegenerative diseases.

Picture of Prof. Catherine Lubetzki, winner of the Pasteur-Weizmann/Servier 2021 Prize

“I am very honored to receive the Pasteur-Weizmann/Servier Prize, which rewards the work of an entire team of clinician-researchers. We are very proud of this award and it encourages us to continue our research”, says Prof. Catherine Lubetzki.


Read the press release



The Pasteur-Weizmann / Servier Prize


Awarded every three years, the Pasteur-Weizmann/Servier Prize is one of the largest research prizes in the world. Created by the Pasteur-Weizmann Council and L’Institut Servier, this prize worth 250,000 euros rewards an internationally recognized researcher, doctor or scientist, and his/her team for a major contribution to a biomedical discovery resulting in a therapeutic application. Its aim is to promote and encourage fundamental research.


L’Institut Servier is a non-profit association whose mission is to develop research in all its forms as well as scientific knowledge for medical progress.


More information on: https://institut-servier.com/fr/prix-pasteur-weizmann-servier




1 – Lubetzki C, Zalc B, Williams A, Stadelmann C, Stankoff B. Remyelination in multiple sclerosis: from basic science to clinical translation. Lancet Neurol. 2020 Aug;19(8):678-688. doi: 10.1016/S1474-4422(20)30140-X. PMID: 32702337.


Last news

Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting!
Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
Patient associations’ perception of pharmaceutical companies: Servier is making progress!